Revenue Cycle

New codes for cardiology procedures added to manual

Briefings on APCs, February 1, 2013

This is an excerpt from a member only article. To read the article in its entirety, please login or subscribe to Briefings on APCs.

In November 2011, the FDA approved ­transcatheter aortic valve replacement (TAVR) to treat aortic valve stenosis for those patients who are not candidates for traditional open-heart surgery. This procedure is also referred to as a transcatheter aortic valve implantation (TAVI).

This is an excerpt from a member only article. To read the article in its entirety, please login or subscribe to Briefings on APCs.

Most Popular